“An initiative to protect the European pharmaceutical supply chain from the entry of falsified medicines.”

The European Medicines Verification Organisation (EMVO) has taken responsibility for advancing the formation of the European Medicines Verification System (EMVS). The EMVS is in accordance with the EU’s Falsified Medicines Directive (FMD) and the Delegated Regulation (DR). IT ensures the implementation of a functioning, secure, interoperable and cost effective system across Europe.
The infiltration of falsified medicines in the European supply chain is a major and continuous threat for the patient health and security. Because patient health and safety is of the utmost importance to the pharmaceutical industry, a comprehensive strategy at European Level is required. Therefore the European Medicines Verification Organisation (EMVO) was created as a joint initiative of EU stakeholders, representing manufacturers (Medicines for Europe, EFPIA, EAEPC), wholesalers (GIRP) and community pharmacists (PGEU).

“The European Medicines Verifiaction Orgnisation is the guarantee of patient security in Europe.”


European Medicines Verification Organisation

The risk of falsified medicines is growing on a global scale. The European Medicines Verification Organisation (EMVO) representing stakeholders united in securing the legal supply chain from falsified medicines.
Read more
The Falsified Medicines Directive (FMD) and the Delegated Regulation (DR) are available in our Documents Overview.

“Medicines Authenticity will be guaranteed by an European end-to-end Verification System.”


European Medicines Verification System

In order to counter the threat of falsified medicines entering the legal supply chain, the European Parliament and Council have released a Directive on Falsified Medicines (2011/62/EU) (amending Directive 2001/83/EC). It aims at improving patient safety by mandating the Marketing Authorisation Holders and manufacturers to put a system in place that is preventing falsified medicines from entering the legal supply chain, the European Medicines Verification System.
Read more

“United with our Stakeholders in securing the legal supply chain from falsified medicines.”


EFPIA – the European Federation of Pharmaceutical Industries and Associations

Membership: Full Member
EFPIA (The European Federation of Pharmaceutical Industries and Associations) represents the research-based pharmaceutical industry operating in Europe. Founded in 1978, its members comprise 33 national pharmaceutical industry associations and 42 leading pharmaceutical companies undertaking research, development and manufacturing of medicinal products in Europe for human use.

Its mission is to promote pharmaceutical research and development and the best conditions in Europe for companies to bring to market medicines that improve human health and the quality of life around the world.

Through its membership, EFPIA represents the common views of more than 1,900 large, medium and small companies including the entire European research-based pharmaceutical sector whose interests also include a significant part of the generics and biosimilars segments. Two specialised groups have been created within EFPIA to address specific issues relating to vaccines (Vaccines Europe, formerly EVM) and the needs of biopharmaceutical companies (EBE – European Biopharmaceutical Enterprises).

Further details about the Federation and its activities can be obtained from:

Leopold Plaza Building, Rue du Trône 108
B-1050, Brussels
Telephone: +32 (0)2 626 25 55
Email: reception@efpia.eu
Website: www.efpia.eu
efpia Logo

Medicines for Europe – the European Generic and Biosimilar Medicines Association

Membership: Full Member
Medicines for Europe represents the generic, biosimilar and value added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership.  Its members employ 160,000 people at over 350 manufacturing and R&D sites in Europe, and invest up to 17% of their turnover in medical innovation.

Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines, whilst also innovating to create new biosimilar medicines and bringing to market value added medicines, which deliver better health outcomes, greater efficiency and/or improved safety in the hospital setting for patients.

Further details about the Federation and its activities can be obtained from:

Medicines for Europe
Aarlenstraat 50
B-1000, Brussels
Telephone: +32 (0)2 736 84 11
Email: info@medicinesforeurope.com
Website: www.medicinesforeurope.com/
Twitter:  @medicinesforEU
Medicines for Europe Logo

PGEU – the Pharmaceutical Group of the European Union

Membership: Full Member
The Pharmaceutical Group of the European Union (PGEU) is the association representing community pharmacists in 33 European countries. In Europe over 400.000 community pharmacists provide services throughout a network of more than 160.000 pharmacies, to an estimated 46 million European citizens daily.

PGEU’s objective is to promote the role of pharmacists as key players in healthcare systems throughout Europe and to ensure that the views of the pharmacy profession are taken into account in the EU decision-making process.

Further details about the Federation and its activities can be obtained from:

Rue du Luxembourg 19
B-1000, Brussels
Telephone: +32 (0)2 238 08 18
Email: pharmacy@pgeu.eu
Website: www.pgeu.eu/en/

GIRP – the European Healthcare Distribution Association

Membership: Full Member
GIRP, the European Healthcare Distribution Association, is the umbrella organisation for pharmaceutical full-line wholesalers and distributors of healthcare products and services in Europe. It represents the national associations of over 750 pharmaceutical wholesalers serving 32 European countries, as well as major international and pan-European healthcare distribution companies. GIRP members employ over 140,000 people and distribute around 15 billion packs of medicines as well as a wide range of healthcare products per year. As the vital link in healthcare, they are committed to developing and providing innovative and efficient healthcare products and services to improve health and wellbeing of patients across Europe.

Further details about the Federation and its activities can be obtained from:

Rue de la loi 26, 10th floor, box 14
B-1040, Brussels
Telephone: +32 (0)2 777 99 77
email: girp@girp.eu
Website: www.girp.eu

EAEPC – the European Association of Euro-Pharmaceutical Companies

Membership: Full Member
The EAEPC (European Association of Euro-Pharmaceutical Companies) is the representative voice of pharmaceutical parallel distribution in Europe. Through national association or individual company membership it encompasses about 100 firms from 23 countries in the European Economic Area (EEA).

The EAEPC’s primary aims are to safeguard the free movement of medicines, as laid down in the EU treaty, and to counteract any attempts to restrict the freedom of choice for the consumer through trading patterns in breach of European competition law. The Association believes that free trade will lead to improvements in health standards through the provision of innovative medicines at lower cost, benefiting statutory healthcare systems, other third-party payers, and the public as both patients and taxpayers, as well as assisting the EU to achieve its objective of a single, internal market.

Further details about the Federation and its activities can be obtained from:

Rue du Commerce 123
B-1000, Brussels
Telephone: +32 (0)2 895 57 35
Email: info@eaepc.org
Website: www.eaepc.org/

HOPE – the European Hospital and Healthcare Federation

Membership: Affiliated Member
HOPE (The European Hospital and Healthcare Federation) represents national public and private hospitals and healthcare associations, national federations of local and regional authorities and national health services. With 37 organisations from the 30 European countries, HOPE covers almost 80% of hospital and social care activity.

HOPE mission is to promote improvements in the health of citizens and a uniformly high standard of hospital care by the European Union, fostering efficiency, effectiveness and humanity in the organisation and operations of hospital and health services.

Further details about the Federation and its activities can be obtained from:

Avenue Marnix 30, box 17, 3rd floor
B-1000, Brussels
Telephone: +32 2 742 13 20
Email: sg@hope.be
Website: www.hope.be
Twitter: @euhospitals

EAHP – the European Association of Hospital Pharmacists

Membership: Affiliated Member
EAHP (The European Association of Hospital Pharmacists) represents more than 21.000 hospital pharmacists in 35 European countries and is the only association of national organisations representing hospital pharmacists at European and international levels.

EAHP mission is to represent and develop the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.

Further details about the Federation and its activities can be obtained from:

Boulevard Brand Whitlock 87, Box 11
1200, Brussels
Telephone: +32 2 669 25 13

Email: info@eahp.eu
Website: www.eahp.eu
Twitter: @EAHPtweet